Sherman Darren

SEC source: 0001104659-26-113320 · tm2626947-1_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,119,402

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025.

F2 · price: The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $6.20 to $6.48. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote.

SEC source: 0001104659-26-104739 · tm2624698-1_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,134,402

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025.

F2 · price: The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $4.88 to $5.06. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote.

SEC source: 0001104659-26-103209 · tm2624220-2_4seq1.xml · nonDerivative · entry 2

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · By son

Disclosed balance after: 2,000

F2 · shares: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · balance_after: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

SEC source: 0001104659-26-103209 · tm2624220-2_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,149,402

F1 · kind: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

SEC source: 0001104659-26-090449 · tm2622228-1_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,154,327

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025.

F2 · price: The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $3.94 to $4.15. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote.

SEC source: 0001104659-26-080333 · tm2619667-1_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,169,327

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025.

F2 · price: The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $4.21 to $4.32. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote.

SEC source: 0001104659-26-069503 · tm2616712-1_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,184,327

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025.

F2 · price: The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $3.81 to $4.01. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote.

SEC source: 0001104659-26-068274 · tm2616050-1_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,199,327

F1 · kind: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

SEC source: 0001104659-26-036168 · tm269936-3_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,204,252

F1 · kind: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

SEC source: 0001104659-26-015323 · tm266316-3_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,237,569

F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 25% of the shares will vest 18 months after February 12, 2026 (the "Issue Date"), (ii) 25% of the shares will vest 24 months after the Issue Date, (iii) 25% of the shares will vest 30 months after the Issue Date and (iv) 25% of the shares will vest 36 months after the Issue Date, subject to the Reporting Person's continuous service through such dates.

SEC source: 0001104659-26-011524 · tm265397-1_4seq1.xml · derivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,974

Underlying: Common Stock · 34,974 shares

Expires 2035-04-23

F1 · date: This date represents the date of vesting of a performance stock option granted on April 23, 2025.

F2 · derivative.exercise_date: The stock option vests over a four-year period as follows: 25% on the April 23, 2026 (the "Vesting Commencement Date") with the remaining 75% vesting in equal installments every three months thereafter on the same day of the month as the Vesting Commencement Date over a three-year period, commencing in the third month after the Vesting Commencement Date.

SEC source: 0001104659-26-000269 · tm261746-1_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 840,569

F1 · kind: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.

SEC source: 0001104659-25-116428 · tm2532314-1_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 846,157

F1 · kind: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.

SEC source: 0001104659-25-087810 · tm2525310-1_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 886,497

F1 · kind: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.

SEC source: 0001104659-25-082636 · tm2524324-3_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 926,837

SEC source: 0001104659-25-075787 · tm2523004-8_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 923,837

F1 · shares: Represents an award of restricted stock units ("RSUs") to the Reporting Person on August 7, 2025 (the "Grant Date"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 33.33% of the shares will vest 24 months after the Grant Date, (ii) 33.33% of the shares will vest 30 months after the Grant Date, and (iii) 33.34% of the shares will vest 36 months after the Grant Date, subject to the Reporting Person's continuous service through such dates.

SEC source: 0001104659-25-055019 · tm2516689-1_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 803,837

F1 · kind: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.

SEC source: 0001104659-25-032331 · tm2511637-2_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 849,680

F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 33.33% of the shares will vest 24 months after April 4, 2025 (the "Issue Date"), (ii) 33.33% of the shares will vest 30 months after the Issue Date, and (iii) 33.34% of the shares will vest 36 months after the Issue Date, subject to the Reporting Person's continuous service through such dates.

SEC source: 0001104659-24-126333 · tm2430395-1_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 733,972

F1 · kind: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units.

F1 · shares: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units.

SEC source: 0001104659-24-098693 · tm2423769-2_4seq1.xml · nonDerivative · entry 2

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 765,787

F1 · shares: The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.

F3 · price: The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.13 to $5.69, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-098693 · tm2423769-2_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 772,691

F1 · shares: The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.

F2 · price: The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.38 to $5.57, inclusive. The reporting person hereby undertakes to provide upon request to the staff of the Securities and Exchange Commission (the "SEC"), the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-097862 · tm2423573-1_4seq1.xml · nonDerivative · entry 3

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 779,495

F1 · shares: The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.

F4 · price: The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.50 to $5.94, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-097862 · tm2423573-1_4seq1.xml · nonDerivative · entry 2

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 786,314

F1 · shares: The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.

F3 · price: The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.61 to $6.14, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-097862 · tm2423573-1_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 793,275

F1 · shares: The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.

F2 · price: The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.19, inclusive. The reporting person hereby undertakes to provide upon request to the staff of the Securities and Exchange Commission (the "SEC"), the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-24-060000 · tm2414108-3_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,112

F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (i) 26,500 RSUs will vest on May 25, 2025, and (ii) the remaining 150,167 RSUs will vest in equal installments on August 25, 2025, November 25, 2025, December 22, 2025, May 25, 2026, August 25, 2026, December 22, 2026, March 25, 2027, May 25, 2027, August 25, 2027, November 25, 2027, March 25, 2028 and May 25, 2028, subject to the Reporting Person's continuous service through such dates.

SEC source: 0001104659-23-083504 · tm2321855-9_4seq1.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 623,445

F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 34% of the shares will vest on the 18-month anniversary of January 26, 2023 (the "Vesting Commencement Date"), (ii) 33% the shares will vest on the two-year anniversary of the Vesting Commencement Date, and (iii) 33% the shares will vest on the three-year anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service through such dates.

SEC source: 0001213900-23-036999 · ownership.xml · derivative · entry 2

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,959

Underlying: Common Stock · 14,959 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the "Merger Agreement"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the "Earnout Shares") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the "Initial Milestone Event") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period.

F2 · derivative.exercise_price: The Initial Milestone Event occurred on April 12, 2023 and 14,959 shares of Common Stock were issued to the Reporting Person on April 19, 2023 in accordance with the Merger Agreement.

F1 · kind: Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the "Merger Agreement"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the "Earnout Shares") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the "Initial Milestone Event") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period.

F2 · kind: The Initial Milestone Event occurred on April 12, 2023 and 14,959 shares of Common Stock were issued to the Reporting Person on April 19, 2023 in accordance with the Merger Agreement.

F1 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the "Merger Agreement"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the "Earnout Shares") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the "Initial Milestone Event") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period.

F2 · price: The Initial Milestone Event occurred on April 12, 2023 and 14,959 shares of Common Stock were issued to the Reporting Person on April 19, 2023 in accordance with the Merger Agreement.

F1 · derivative.exercise_date: Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the "Merger Agreement"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the "Earnout Shares") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the "Initial Milestone Event") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period.

F2 · derivative.exercise_date: The Initial Milestone Event occurred on April 12, 2023 and 14,959 shares of Common Stock were issued to the Reporting Person on April 19, 2023 in accordance with the Merger Agreement.

F1 · derivative.expiration_date: Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the "Merger Agreement"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the "Earnout Shares") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the "Initial Milestone Event") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period.

F2 · derivative.expiration_date: The Initial Milestone Event occurred on April 12, 2023 and 14,959 shares of Common Stock were issued to the Reporting Person on April 19, 2023 in accordance with the Merger Agreement.

SEC source: 0001213900-23-036999 · ownership.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,778

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the "Merger Agreement"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the "Earnout Shares") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the "Initial Milestone Event") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period.

F2 · kind: The Initial Milestone Event occurred on April 12, 2023 and 14,959 shares of Common Stock were issued to the Reporting Person on April 19, 2023 in accordance with the Merger Agreement.

F1 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the "Merger Agreement"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the "Earnout Shares") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the "Initial Milestone Event") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period.

F2 · price: The Initial Milestone Event occurred on April 12, 2023 and 14,959 shares of Common Stock were issued to the Reporting Person on April 19, 2023 in accordance with the Merger Agreement.

SEC source: 0001213900-23-006176 · ownership.xml · derivative · entry 6

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,743

Underlying: Common Stock · 6,743 shares

Expires 2032-04-11

F11 · price: Received in the Business Combination in exchange for an incentive stock option to acquire 14,500 shares of Legacy Orchestra Common Stock for $1.89 per share.

F10 · derivative.exercise_date: The incentive stock options vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with the end of the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is April 12, 2022.

SEC source: 0001213900-23-006176 · ownership.xml · derivative · entry 5

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,250

Underlying: Common Stock · 116,250 shares

Expires 2023-01-19

F9 · price: Received in the Business Combination in exchange for a nonstatutory stock option to acquire 250,000 shares of Legacy Orchestra Common Stock for $4.65 per share.

F8 · derivative.exercise_date: The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with the end of the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is January 20, 2023.

SEC source: 0001213900-23-006176 · ownership.xml · derivative · entry 4

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 508,397

Underlying: Common Stock · 508,397 shares

Expires 2023-08-07

F7 · price: Received in the Business Combination in exchange for a nonstatutory stock option to acquire 1,093,327 shares of Legacy Orchestra Common Stock for $4.65 per share.

F6 · derivative.exercise_date: The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with the end of the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022.

SEC source: 0001213900-23-006176 · ownership.xml · derivative · entry 3

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,500

Underlying: Common Stock · 46,500 shares

Expires 2032-04-11

F5 · price: Received in the Business Combination in exchange for a nonstatutory stock option to acquire 100,000 shares of Legacy Orchestra Common Stock for $2.00 per share.

F4 · derivative.exercise_date: The nonstatutory stock options ("NSOs") vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with the end of the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is April 12, 2022.

SEC source: 0001213900-23-006176 · ownership.xml · derivative · entry 2

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310,321

Underlying: Common Stock · 310,321 shares

Expires 2028-08-07

F3 · price: Received in the Business Combination in exchange for a nonstatutory stock option to acquire 667,357 shares of Legacy Orchestra Common Stock for $2.00 per share.

SEC source: 0001213900-23-006176 · ownership.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,189

F1 · shares: These securities were issued on the closing date of the merger (the "Business Combination") contemplated by the Agreement and Plan of Merger, dated as of July 4, 2022, as amended by Amendment No. 1 thereto dated as of July 21, 2022 and Amendment No. 2 thereto dated as of November 21, 2022 (as amended, the "Merger Agreement"), by and among Orchestra BioMed Holdings, Inc. (f/k/a Health Sciences Acquisitions Corporation 2) ("HSAC2"), HSAC Olympus Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HSAC2, and Orchestra BioMed, Inc., a Delaware corporation ("Legacy Orchestra"), in exchange for Legacy Orchestra securities.

F2 · price: Received in the Business Combination in exchange for 147,998 shares of common stock of Legacy Orchestra ("Legacy Orchestra Common Stock").

SEC source: 0001213900-23-037010 · ownership.xml · derivative · entry 2

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,918

Underlying: Common Stock · 29,918 shares

Expires not disclosed

F1 · security: On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently (1) misstated the number of shares of Common Stock acquired by the Reporting Person in the Business Combination (defined below) as 68,189 instead of the correct 68,819 shares of Common Stock and (2) omitted the right to receive Earnout Shares (defined below). In accordance with Instructions 9(a) and 9(b) to Form 4, this amendment is filed solely to (1) correct the amounts in Table I, Column 4 and Column 5 and (2) add the lines of information to Table II included here; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing.

F4 · derivative.exercise_price: Pursuant to the Merger Agreement, the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the "Earnout Shares") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period.

F4 · price: Pursuant to the Merger Agreement, the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the "Earnout Shares") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period.

F4 · derivative.exercise_date: Pursuant to the Merger Agreement, the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the "Earnout Shares") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period.

F4 · derivative.expiration_date: Pursuant to the Merger Agreement, the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the "Earnout Shares") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period.

SEC source: 0001213900-23-037010 · ownership.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,819

F1 · shares: On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently (1) misstated the number of shares of Common Stock acquired by the Reporting Person in the Business Combination (defined below) as 68,189 instead of the correct 68,819 shares of Common Stock and (2) omitted the right to receive Earnout Shares (defined below). In accordance with Instructions 9(a) and 9(b) to Form 4, this amendment is filed solely to (1) correct the amounts in Table I, Column 4 and Column 5 and (2) add the lines of information to Table II included here; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing.

F2 · shares: These securities were issued on the closing date of the merger (the "Business Combination") contemplated by the Agreement and Plan of Merger, dated as of July 4, 2022, as amended by Amendment No. 1 thereto dated as of July 21, 2022 and Amendment No. 2 thereto dated as of November 21, 2022 (as amended, the "Merger Agreement"), by and among Orchestra BioMed Holdings, Inc. (f/k/a Health Sciences Acquisitions Corporation 2) ("HSAC2"), HSAC Olympus Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HSAC2, and Orchestra BioMed, Inc., a Delaware corporation ("Legacy Orchestra"), in exchange for Legacy Orchestra securities.

F3 · price: Received in the Business Combination in exchange for 147,998 shares of common stock of Legacy Orchestra ("Legacy Orchestra Common Stock").

F1 · balance_after: On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently (1) misstated the number of shares of Common Stock acquired by the Reporting Person in the Business Combination (defined below) as 68,189 instead of the correct 68,819 shares of Common Stock and (2) omitted the right to receive Earnout Shares (defined below). In accordance with Instructions 9(a) and 9(b) to Form 4, this amendment is filed solely to (1) correct the amounts in Table I, Column 4 and Column 5 and (2) add the lines of information to Table II included here; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing.

SEC source: 0001213900-23-041609 · ownership.xml · derivative · entry 2

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,250

Underlying: Common Stock · 116,250 shares

Expires 2033-01-19

F1 · security: On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently (i) misstated the expiration dates of two classes of nonstatutory stock options ("NSOs") and (ii) misstated the vesting schedules for such NSOs. In accordance with Instruction 9(b) to Form 4, this amendment is filed solely to (i) correct the incorrect expiration dates in Table II, Column 6 to August 17, 2032 and January 19, 2033, respectively, and (ii) correct the incorrect vesting schedules set forth in the footnotes corresponding to such NSOs, which are reproduced in this amendment with the correct vesting schedules; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing.

F5 · price: Received in the Business Combination in exchange for a nonstatutory stock option to acquire 250,000 shares of Legacy Orchestra Common Stock for $4.65 per share.

F4 · derivative.exercise_date: The NSOs vest over a three-year period as follows: (i) 44.4% of the underlying shares vested on the grant date and (ii) 55.6% of the underlying shares will vest in equal installments on a quarterly basis on the last day of each quarter, starting with March 31, 2023, subject to the Reporting Person's continuous service through such dates. The grant date is January 20, 2023.

SEC source: 0001213900-23-041609 · ownership.xml · derivative · entry 1

Sherman Darren · CIK 0001723524 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 508,397

Underlying: Common Stock · 508,397 shares

Expires 2032-08-17

F1 · security: On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently (i) misstated the expiration dates of two classes of nonstatutory stock options ("NSOs") and (ii) misstated the vesting schedules for such NSOs. In accordance with Instruction 9(b) to Form 4, this amendment is filed solely to (i) correct the incorrect expiration dates in Table II, Column 6 to August 17, 2032 and January 19, 2033, respectively, and (ii) correct the incorrect vesting schedules set forth in the footnotes corresponding to such NSOs, which are reproduced in this amendment with the correct vesting schedules; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing.

F3 · price: Received in the Business Combination in exchange for a nonstatutory stock option to acquire 1,093,327 shares of Legacy Orchestra Common Stock for $4.65 per share.

F2 · derivative.exercise_date: The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with September 30, 2022, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022.

SEC source: 0001493152-22-004066 · ownership.xml · derivative · entry 1

Sherman Darren · CIK 0001723524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock, par value $0.0001 per share · 50,000 shares

Expires 2032-02-10

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan"). The option becomes exercisable as to 100% of the shares on February 10, 2023. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan.

SEC source: 0001493152-22-000690 · ownership.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,602

F1 · shares: On January 5, 2022, Reporting Person was granted 90,521 shares of Common Stock as compensation in lieu of cash for Reporting Persons service as a director for calendar year 2022, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan").

SEC source: 0001213900-21-010583 · ownership.xml · derivative · entry 4

Sherman Darren · CIK 0001723524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock, par value $0.0001 per share · 30,000 shares

Expires 2031-02-17

F4 · derivative.exercise_date: The option award was made in accordance with the terms of the 2016 Plan. The option becomes exercisable as to 100% of the shares on February 17, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan.

SEC source: 0001213900-21-010583 · ownership.xml · nonDerivative · entry 2

Sherman Darren · CIK 0001723524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,081

F2 · shares: On February 17, 2021, Reporting Person was granted 22,191 shares of Common Stock as compensation in lieu of cash for Reporting Persons service as a director for calendar year 2021, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan").

SEC source: 0001213900-21-010583 · ownership.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,890

F1 · shares: On February 17, 2021, Reporting Person was granted 30,000 Common Stock restricted stock units. The restricted stock units vest as to 100% of the shares on February 17, 2022. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan").

SEC source: 0001213900-21-002120 · ownership.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,890

F1 · shares: On January 12, 2021, Reporting Person was granted 9,144 shares of Common Stock as compensation for Reporting Persons service as a director during the fourth quarter of 2020, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan").

SEC source: 0001213900-20-043390 · ownership.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,746

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9656 to $0.97, inclusive. Reporting Person undertakes to provide to Motus GI Holdings, Inc., any security holder of Motus GI Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001213900-20-031109 · ownership.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,746

F1 · shares: On October 12, 2020, Reporting Person was granted 10,346 shares of Common Stock as compensation for Reporting Persons service as a director during the third quarter of 2020, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan").

SEC source: 0001213900-20-017345 · ownership.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,400

F1 · shares: On July 10, 2020, Reporting Person was granted 7,900 shares of Common Stock as compensation for Reporting Persons service as a director during the second quarter of 2020, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan").

SEC source: 0001213900-20-002937 · ownership.xml · derivative · entry 4

Sherman Darren · CIK 0001723524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock, par value $0.0001 per share · 12,500 shares

Expires 2030-02-06

F5 · derivative.exercise_date: The option award was made in accordance with the terms of the 2016 Plan. The option becomes exercisable as to 50% of the shares on February 6, 2021, and the remaining shares will become exercisable on February 6, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan.

F2 · balance_after: In prior reports, Reporting Person reported indirect beneficial ownership of (A) 109,792 shares of Issuer Common Stock held by Orchestra Medical Ventures II, L.P. ("OMV II"), (B) a warrant to purchase 108,838 shares of Issuer Common Stock held by OMV II, (C) a warrant to purchase 106,980 shares of Issuer Common Stock held by OMV II, (D) 83,352 shares of Issuer Common Stock held by Orchestra Medical Ventures II Reserve, L.P. ("OMV Reserve"), (E) 1,159,968 shares of Issuer Common Stock held by Orchestra MOTUS Co-Investment Partners, LLC ("OMCP"), (F) a warrant to purchase 115,997 shares of Issuer Common Stock held by OMCP, and (G) a warrant to purchase 69,139 shares of Issuer Common Stock held by OMCP. Each of OMV II, OMV Reserve and OMCP distributed all of their securities of Issuer on a pro rata basis to their members, for no consideration, on 12/31/2019 and Reporting Person retained no direct or indirect beneficial ownership of any shares of Issuer Common Stock or warrants to purchase shares of Issuer Common Stock pursuant to such pro rata distributions.

SEC source: 0001213900-20-002937 · ownership.xml · nonDerivative · entry 1

Sherman Darren · CIK 0001723524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,500

F1 · shares: On February 6, 2020, Reporting Person was granted 12,500 Common Stock restricted stock units. The restricted stock units vest as to 50% of the shares on February 6, 2021, and the remaining restricted stock unit shares vest on February 6, 2022. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan").

F2 · balance_after: In prior reports, Reporting Person reported indirect beneficial ownership of (A) 109,792 shares of Issuer Common Stock held by Orchestra Medical Ventures II, L.P. ("OMV II"), (B) a warrant to purchase 108,838 shares of Issuer Common Stock held by OMV II, (C) a warrant to purchase 106,980 shares of Issuer Common Stock held by OMV II, (D) 83,352 shares of Issuer Common Stock held by Orchestra Medical Ventures II Reserve, L.P. ("OMV Reserve"), (E) 1,159,968 shares of Issuer Common Stock held by Orchestra MOTUS Co-Investment Partners, LLC ("OMCP"), (F) a warrant to purchase 115,997 shares of Issuer Common Stock held by OMCP, and (G) a warrant to purchase 69,139 shares of Issuer Common Stock held by OMCP. Each of OMV II, OMV Reserve and OMCP distributed all of their securities of Issuer on a pro rata basis to their members, for no consideration, on 12/31/2019 and Reporting Person retained no direct or indirect beneficial ownership of any shares of Issuer Common Stock or warrants to purchase shares of Issuer Common Stock pursuant to such pro rata distributions.

SEC source: 0001615774-19-002637 · s116115_form4.xml · derivative · entry 1

Sherman Darren · CIK 0001723524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock, par value $0.0001 per share · 25,000 shares

Expires 2029-02-13

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan"). The option becomes exercisable as to 50% of the shares on February 13, 2020, and the remaining shares will become exercisable on February 13, 2021. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan.